My primary hypothesis is that GAS6/MERTK signaling is upregulated in the setting of inflammation, leading to enhanced platelet activation responses, increased platelet-leukocyte interactions, and subsequent thrombosis. Therefore, we believe inhibition of this pathway will decrease thromboinflammation. MERTK is a receptor tyrosine kinase expressed on the platelet surface that, when stimulated by its plasma-based ligand GAS6, leads to augmentation of platelet activation responses. I have shown that inhibition of this signaling axis, either by anti-MERTK small molecule inhibitor (UNC2025) or a novel soluble MERTK splice variant (iMer) decreases in vitro platelet activation in functional assays and in vivo thrombosis in murine models. I also recently demonstrated that plasma GAS6 levels were elevated in children with thrombosis compared to healthy controls, suggesting that GAS6 may also mediate thrombosis (potentially through its ability to bridge membrane-bound phosphatidylserine and MERTK). In this proposed project, I will rigorously investigate the role of inflammation in platelet activation and thrombosis, as well as the specific mechanisms by which inhibition of GAS6/MERTK signaling impacts thromboinflammation. Though I already have a strong research base in platelet activation response assays and murine models of thrombosis, this proposal provides the experimental skills and knowledge base needed to evaluate the contributions of the inflammatory system in this particular context. This additional training will allow me to continue developing as a physician-scientist and execute the transition to an independent basic- translational research career in thromboinflammation. Herein, I propose three specific aims to 1) characterize the effect of inflammation upon GAS6/MERTK signaling and subsequent platelet activation in vitro and thrombosis in vivo, 2) define the mechanism through which GAS6/MERTK signaling impacts thromboinflammation, and 3) determine the role of iMer in regulating GAS6/MERTK signaling in platelets. My mentorship team consists of recognized leaders in functional assays of platelet activation and murine models of thrombosis (Dr. Jorge Di Paola, primary mentor), and cell-cell interactions in the setting of inflammation (Dr. Sean Colgan, co-mentor). The training plan clearly outlines how I will advance my research career development by building upon my previous studies and experience using the proposed research aims, didactic course-work, attendance at local and national meeting, and guidance from my mentorship team and scholarship oversight committee. I specifically designed the proposed project and associated career development plan to facilitate my transition to independent investigator with the long-term goal of developing novel strategies to decrease inflammation-related thrombosis.

Public Health Relevance

Public Health Relevance: The proposed project aims to investigate the signaling mechanisms underlying platelet activation and thrombosis in the context of inflammation. This research is quite relevant to public health in that current anticoagulant strategies are imperfect and the studies proposed herein to determine the role of platelet activation signaling in thromboinflammation may lead to subsequent development of rational therapies to treat and/or prevent thrombosis.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Clinical Investigator Award (CIA) (K08)
Project #
Application #
Study Section
NHLBI Mentored Clinical and Basic Science Review Committee (MCBS)
Program Officer
Yang, Yu-Chung
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Versiti Wisconsin, Inc.
United States
Zip Code